Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
We elucidated the ultrasound parameters to promote the antifibrogenic and anti-inflammatory effects by short chain fatty acids. Butyrate is a fatty acid having the most potent physiological action among short chain fatty acids. We found the antifibrogenic effects of butyrate in human dermal fibroblasts, keloid fibroblasts and pterygium fibroblasts, and facilitatory effects of low-intensity ultrasound (0.1-0.5 W/cm2) for the antifibrogenic and anti-inflammatory effects by butyrate. In addition, we found the promotional effects of low-intensity ultrasound on histone acetylation by a low-concentration of butyrate.
|